BCTXW
BriaCell Therapeutics Corp. Warrant
BCTXW
BCTXW
7 hedge funds and large institutions have $4.26M invested in BriaCell Therapeutics Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
$619K
Puts
$3.33M
Net Calls
-$2.71M
Net Calls Change
-$509K
Top Buyers
| 1 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$205K |
| 2 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$90.2K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.84K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
M
1
Murchinson
Toronto,
Ontario, Canada
| $1.51M | – | – | – |
|
|
AC
2
Armistice Capital
New York
| $1.08M | – | – | – |
|
|
PFM
3
Privium Fund Management
Amsterdam,
Netherlands
| $710K | +$205K | +78,837 | +40% |
|
|
KJHP
4
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $610K | +$90.2K | +31,440 | +17% |
|
|
RAM
5
Redmond Asset Management
Henrico,
Virginia
| $215K | – | – | – |
|
|
ZCA
6
Zeke Capital Advisors
Berwyn,
Pennsylvania
| $129K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $8K | -$5.84K | -2,140 | -42% |
|